Epigenomics AG
EPGNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $693 | $386 | $1,337 | $345 |
| - Cash | $960 | $2,104 | $10,036 | $22,963 |
| + Debt | $11,783 | $11,889 | $841 | $460 |
| Enterprise Value | $11,516 | $10,171 | -$7,858 | -$22,158 |
| Revenue | $0 | $339 | $485 | $6,203 |
| % Growth | -100% | -30.1% | -92.2% | – |
| Gross Profit | -$12 | $282 | $365 | $6,067 |
| % Margin | – | 83.2% | 75.3% | 97.8% |
| EBITDA | -$3,458 | -$3,614 | -$11,222 | -$1,939 |
| % Margin | – | -1,065.2% | -2,313.8% | -31.3% |
| Net Income | -$3,470 | -$4,464 | -$12,024 | -$2,428 |
| % Margin | – | -1,315.8% | -2,479.2% | -39.1% |
| EPS Diluted | -3.96 | -5.23 | -14.78 | -4.33 |
| % Growth | 24.3% | 64.6% | -241.3% | – |
| Operating Cash Flow | – | -$5,711 | -$12,024 | -$4,152 |
| Capital Expenditures | – | -$3 | -$1,365 | -$35 |
| Free Cash Flow | – | -$5,714 | -$13,389 | -$4,187 |